谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Individualized Starting Dose Of Niraparib In Chinese Patients With Platinum-Sensitive Recurrent Ovarian Cancer (Psroc): A Randomized, Double-Blind, Placebo-Controlled, Phase Iii Trial (Nora)

X. Wu,J. Zhu,R. Yin,J. Yang,J. Liu, J. Wang, L. Wu,Z. Liu,Y. Gao,D. Wang,G. Lou,H. Yang,Q. Zhou,B. Kong,Y. Huang,L. Chen,G. Li,R. An,K. Wang, Y. Zhang

Annals of Oncology（2020）

引用 3|浏览73
暂无评分
关键词
niraparib,ovarian cancer,platinum-sensitive,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要